Ertapenem Resistance ofEscherichia coli
Marie-Frédérique Lartigue, Laurent Poirel, Claire Poyart, Hélène Réglier‐Poupet, Patrice Nordmann
Abstract
Open-access reader
Marie-Frédérique Lartigue, Laurent Poirel, Claire Poyart, Hélène Réglier‐Poupet, Patrice Nordmann
Abstract
Open-access reader
An ertapenem-resistant Escherichia coli isolate was recovered from peritoneal fluid in a patient who had been treated with imipenem/cilastatin for 10 days. Ertapenem resistance may be explained by a defect in the outer membrane protein and production of extended-spectrum beta-lactamase CTX-M-2.
OpenAlex reports 96 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
An ertapenem-resistant Escherichia coli isolate was recovered from peritoneal fluid in a patient who had been treated with imipenem/cilastatin for 10 days. Ertapenem resistance may be explained by a defect in the outer membrane protein and production of extended-spectrum beta-lactamase CTX-M-2.
Key concepts: Ertapenem, Escherichia coli, Microbiology, Imipenem, Bacterial outer membrane, Meropenem, Enterobacteriaceae, Biology